期刊文献+

二甲双胍改善多囊卵巢综合征患者的胰岛素抵抗及炎症

下载PDF
导出
摘要 40例PCOS患者分为肥胖组和非肥胖组,检测Met治疗前后患者的血脂谱、胰岛素抵抗指数(HOMA-IR)、C反应蛋白(CRP)及白介素2(IL-2)的变化。结果:肥胖组的血脂谱和HOMA-IR高于非肥胖组,两组的CRP及IL-2差异没有统计学意义。经过16周Met治疗后,两组的血脂谱、HOMA-IR、CRP及IL-2明显下降。结论:Met可以改善PCOS的患者的IR及炎症。
出处 《实用糖尿病杂志》 2010年第3期34-35,共2页 Journal of Practical Diabetology
  • 相关文献

参考文献7

  • 1Boulman N, Levy Y,et al. Increased C - reactive protein level in the polyeystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab 2004;89(5) :2160.
  • 2The Rotterdam ESHRE /ASRM Sponsored PCOS Consensus Workshop Group. Rivised 2003 consensus on diagnostic criteria and long term health risked related to polycystic ovary syndrome. Fertil Steril 2004;81:19225.
  • 3Carmina E, Bucchieri S, Esposito A, et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 2007 ;92 (7) :250022505.
  • 4Kelly CC, Lyall H, et al. Low grade chronic inflammation in woman with polycystie ovarian syndromcl. Clin Endocrinol Metab 2001 ;86 (6) :2453.
  • 5Padhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis ? Eur Heart J 2003 ;23:831.
  • 6MohligM, Spangcr J, ct al. The polycystic ovary syndrome per sc is not associated with increased chronic inflammation. Euron J of Endocrin 2004;150:525 -532.
  • 7Lund SS, Tarnow L, Stehouwer CDA, et al. Impact of metformin versus repaglinide on non - glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non - obese patients with type 2 diabetes. Euron J of Endocrin 2008 ; 158 : 631 - 641.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部